Antithrombotic and thrombolytic therapy for valvular disease: can this guideline apply to Chinese? [electronic resource]
- Chest May 2013
- 1513-1514 p. digital
Publication Type: Letter; Comment
1931-3543
10.1378/chest.12-3077 doi
Evidence-Based Medicine Fibrinolytic Agents--therapeutic use Heart Valve Diseases--complications Hemorrhage--chemically induced Humans Societies, Medical Thromboembolism--drug therapy Thrombolytic Therapy